Our locations are open for appointments and procedures. See how we're providing safe in-person care and telemedicine visits.

(Nuestras facilidades están abiertas para citas y procedimientos. Vea cómo brindamos atención segura en persona y visitas por medio de telemedicina.)
 

Learn More (Aprenda Más)
Search temple health
EXPLORE TEMPLEHEALTH.ORG
ADDITIONAL LINKS

Neurosciences Center

800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Neurosciences Center

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke

view all Clinical Trials

Overview

Objectives

  • Primary: To test the hypothesis that apixaban is superior to aspirin for the prevention of recurrent stroke in patients with cryptogenic ischemic stroke and atrial cardiopathy.
  • Secondary: To test the hypothesis that the relative efficacy of apixaban over aspirin increases with the severity of atrial cardiopathy.

Clinical Trial Information

Protocol

CIRB # MOD06_2017-1183C-077 NCT03192215

Phase

3

Condition(s)

Stroke

Investigator

Paul Katz, MD

Coordinator

Sandra Combs
215-707-7845

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, call 215-707-7845 or email sandra.combs@tuhs.temple.edu.

Full Title

AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke